Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriflunomide vs Interferon Beta-1a in Relapsing MS
NCT00883337Phase 3Completed
- Sponsor
- Sanofi
- Start
- Apr 2009
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 13
01
Overview
Phase 3, randomised, single-blind trial of teriflunomide in multiple sclerosis (MS) (3 arms), sponsored by Sanofi. Primary endpoint: Time to Failure (Relapse or Discontinuation). Started Apr 2009; status: completed.
02
Drugs
teriflunomide
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00883337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00883337.